CSI Market
Sign In | Register

Biocryst Pharmaceuticals Inc (BCRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BCRX Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Biocryst Pharmaceuticals Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent154.97
Restricted Cash and Cash Equivalents, Current0.48
Short-term Investments, Total197.83
Cash & Short-term Investments351.00
Accounts receivable110.76
Inventories6.06
Disposal Group, Including Discontinued Operation, Assets, Current AS0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current14.82
Total Current Assets484.68
Equipment/Property/Plant Net9.06
Long-term investments0.00
Disposal Group, Including Discontinued Operation, Assets, Noncurrent AS0.00
Other Assets, Noncurrent64.11
Total Assets557.85
Liabilities
Accounts Payable, Current AC11.46
Accrued Liabilities, Current AC121.90
Other Liabilities, Current75.49
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.00
Total Current Liabilities208.85
Long-term debt395.40
Total Long-term Debt395.40
Derivative Liability, Noncurrent DE0.06
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent LI0.00
Other liabilities, Noncurrent407.83
Operating Lease Liability Current1.86
Finance Lease Liability Noncurrent1.17
Operating Lease Liability Noncurrent11.12
Total Liabilities1,012.14
Stockholders' Equity
Common Stock Value2.55
Additional Paid In Capital Common Stock1,693.28
Retained Earnings / Accumulated Deficit-2,149.60
Accumulated Other Comprehensive Income-0.53
Other Equity-0.53
Common Stockholder's Equity-454.29
Total Stockholder's Equity-454.29
Liabilities & Stockholder's Equity557.85
4 historic quarters locked

Sign in to unlock the full Biocryst Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Biocryst Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-053300

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.